Merck, Novocure Team Up On Lung Cancer Treatment; Trial Set For 2H20
Merck (MRK) and Novocure (NVCR) have entered into a clinical trial collaboration agreement to develop
Merck (MRK) and Novocure (NVCR) have entered into a clinical trial collaboration agreement to develop